Skip to content

Clinical trials

Observational Cardiovascular Diseases trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Phase: Observational Country / region: Russia Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20111
20131
20141
20181
20204
20213
20223
20233
20241
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting5
Active, not recruiting2
Enrolling by invitation2
Not yet recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
I.M. Sechenov First Moscow State Medical University6
National Medical Research Center for Therapy and Preventive Medicine5
Bayer2
Eurasian Association of Therapists2
Tomsk National Research Medical Center of the Russian Academy of Sciences2
Akrikhin1
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health1
Meshalkin Research Institute of Pathology of Circulation1
Novartis Pharmaceuticals1
Population Health Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases26
Atherosclerosis4
COVID-194
Heart Failure3
Thromboembolism3
Coronary Artery Disease2
Diabetes Mellitus2
Heart Diseases2
Noncommunicable Diseases2
Pulmonary Disease, Chronic Obstructive2

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.